Equine CEA antibody and antigen (recombinant protein)
Diagnostic anti-Equine CEA antibodies pairs and antigen for animal health (animal Equine/Horse breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-CEA-Ag01 | Recombinant Equine CEA protein | 3090 |
GMP-EQU-CEA-Ab01 | Anti-Equine CEA mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-CEA-Ab02 | Anti-Equine CEA mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-CEA-Ab03 | Anti-Equine CEA human monoclonal antibody (mAb) | 1953 |
GMP-EQU-CEA-Ab04 | Anti-Equine CEA human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-EQU-CEA-Ag01 |
Product Name | Recombinant Equine CEA protein |
Target/Biomarker | Bovine Lactoferrin () |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Bovine Lactoferrin antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of animal Equine/Horse with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer. |
Tag | His |
Products description | Recombinant Equine CEA protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-CEA-Ab01, GMP-EQU-CEA-Ab02 |
Product Name | Anti-Equine CEA mouse monoclonal antibody (mAb) |
Target/Biomarker | Bovine Lactoferrin () |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Bovine Lactoferrin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies in level test of animal Equine/Horse with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer. |
Tag | mFc |
Products description | Anti-Equine CEA mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-CEA-Ab03, GMP-EQU-CEA-Ab04 |
Product Name | Anti-Equine CEA human monoclonal antibody (mAb) |
Target/Biomarker | Bovine Lactoferrin () |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Bovine Lactoferrin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies in level test of animal Equine/Horse with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer. |
Tag | hFc |
Products description | Anti-Equine CEA human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti- antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Carcinoembryonic Antigen (CEA) in horses (equines) is a glycoprotein biomarker with important implications in various physiological and pathological processes. Structurally, CEA belongs to the immunoglobulin superfamily and features multiple immunoglobulin-like domains, enabling its role in cell adhesion processes and tissue development. While CEA is actively produced during fetal development, its presence in healthy adult horses is typically limited to very low levels. During fetal development, CEA is involved in cell adhesion, promoting the formation and integrity of various tissues. Its function is primarily to mediate interactions between cells, contributing to the organization and stability of tissues during embryonic growth.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.